Various studies revealed their relevance to breast cancer risk, where a polymorphism occurred in the FGFR2 intron 2 location and modulated the interaction of two transcription factors named Oct-1/Runx2 and C/EBPb. This evidence concerns the gene FGFR2 and breast carcinoma.